Article
Intervention therapies for insulin-dependent diabetes.
Autoimmunity - 1 Jan 1993
Muir A, Schatz D A, Pozzilli P, MacLaren N K
Abstract excerpt
Treatment of insulin-dependent diabetes remains problematic since there continues to be high rates of morbidity and mortality among affected patients. Good outcomes are most likely to be more common among patients who maintain endogenous insulin reserves for the longest time following diagnosis....
Topics
- Animals
- Autoantigens
- Autoimmune Diseases
- Clinical Trials as Topic
- Diabetes Mellitus, Type 1
- Drug Evaluation, Preclinical
- Female
- Genetic Predisposition to Disease
- Humans
- Immunosuppressive Agents
- Immunotherapy
- Insulin